MedTechIQ_3Helix InSight Engine-Beta
Preview
Open in TheBrain
Triple Helix Discovery Engine
Triple Helix Framework
Industry
Architects: Small & Medium Size Business (SMBs), Product Development, De-Risking, Validation, Building Niche & Emerging Markets
Architects: Multiple Sclerosis (MS)
Clene Inc. (NASDAQ: CLNN)*
Organization & Developments: Clene
Parents
Clene Inc. (NASDAQ: CLNN)*
Children
*Clene Inc. (NASDAQ:CLNN) is a Salt Lake City based clinical-stage biopharmaceutical concern focused on the development of therapies that leverage its expertise in nanotechnology.
*The company has one nanotherapeutic in the clinic undergoing evaluation in three neurological indications and a second asset that is being assessed as an anti-viral and anti-bacterial agent in one study.
2022 Startup's gold nanocrystal ALS drug flops a PhII trial, a reminder of the disease's obstacles despite Amylyx OK
2022: Clene Inc.: A First Take_seekingalpha.com
Clene Nanomedicine
Jumps
Finance & Acquisitions: Clene
Key People: Clene